Figure 4.
Potential zymosan and empagliflozin interactions with TLR2. (A) Zymosan may interact via multiple hydrogen bonds (dotted yellow lines) with R423, V425, D444, S445, and S447 amino acid residues of TLR-2. (B) Empagliflozin has a moiety identical to Zymosan. (C) The zymosan-like moiety may enable Empagliflozin to interact withV425 and S445 amino acid residues of TLR-2 via H-bond formation.